dc.contributor.author | Yiğit Kaya, Süreyya | |
dc.contributor.author | Aşkın, Abdullah Emre | |
dc.contributor.author | Bektaş, Şebnem | |
dc.contributor.author | Çakır, Aslı | |
dc.contributor.author | Gökmen Sevindik, Ömür | |
dc.date.accessioned | 2023-05-24T07:42:19Z | |
dc.date.available | 2023-05-24T07:42:19Z | |
dc.date.issued | 2023 | en_US |
dc.identifier.citation | Yiğit Kaya, S., Aşkın, A. E., Bektaş, Ş., Çakır, A. ve Gökmen Sevindik, Ö. (2023). Newly onset cytopenias not always indicate a relapsing AML after allogeneic HSCT, a case of non-destructive post transplant lymphoproliferative disorder. Leukemia Research Reports, 19. https://doi.org/10.1016/j.lrr.2023.100369 | en_US |
dc.identifier.issn | 2213-0489 | |
dc.identifier.uri | https://doi.org/10.1016/j.lrr.2023.100369 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12511/10965 | |
dc.description.abstract | Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains an effective option for the treatment of intermediate and high-risk Acute myeloid leukemia (AML). Post-transplant lymphoproliferative disorder (PTLD) is related to the intensity of post-transplant immunosuppression. Although Epstein-Barr virus (EBV) seropositivity and reactivation can be a major risk factor for PTLD. A few PTLDs could be EBV negative. There are a very limited number of PTLD cases following HSCT in patients with AML. We present a differential diagnosis of cytopenias after allo-HSCT. This is the first report of an AML patient developing bone marrow EBV-negative PTLD relatively late in their post-transplant course. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Elsevier Ltd | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | * |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Acute Myeloid Leukemia (AML) | en_US |
dc.subject | Epstein-Barr Virus | en_US |
dc.subject | Post Transplant Lymphoproliferative Disorder | en_US |
dc.subject | Rituximab | en_US |
dc.title | Newly onset cytopenias not always indicate a relapsing AML after allogeneic HSCT, a case of non-destructive post transplant lymphoproliferative disorder | en_US |
dc.type | article | en_US |
dc.relation.ispartof | Leukemia Research Reports | en_US |
dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Tıbbi Patoloji Ana Bilim Dalı | en_US |
dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı | en_US |
dc.authorid | 0000-0003-0128-6947 | en_US |
dc.authorid | 0000-0001-9636-4113 | en_US |
dc.identifier.volume | 19 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.doi | 10.1016/j.lrr.2023.100369 | en_US |
dc.institutionauthor | Yiğit Kaya, Süreyya | |
dc.institutionauthor | Aşkın, Abdullah Emre | |
dc.institutionauthor | Bektaş, Şebnem | |
dc.institutionauthor | Çakır, Aslı | |
dc.institutionauthor | Gökmen Sevindik, Ömür | |
dc.identifier.wos | 001051640000001 | en_US |
dc.identifier.scopus | 2-s2.0-85156144672 | en_US |
dc.identifier.pmid | 37213444 | en_US |
dc.identifier.scopusquality | Q3 | en_US |